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Abstract
Although caloric restriction (CR) has been shown to increase lifespan in various animal models, the mechanisms underlying
this phenomenon have not yet been revealed. We developed an in vitro system to mimic CR by reducing glucose
concentration in cell growth medium which excludes metabolic factors and allows assessment of the effects of CR at the
cellular and molecular level. We monitored cellular proliferation of normal WI-38, IMR-90 and MRC-5 human lung fibroblasts
and found that glucose restriction (GR) can inhibit cellular senescence and significantly extend cellular lifespan compared
with cells receiving normal glucose (NG) in the culture medium. Moreover, GR decreased expression of p16
INK4a (p16), a well-
known senescence-related gene, in all of the tested cell lines. Over-expressed p16 resulted in early replicative senescence in
glucose-restricted cells suggesting a crucial role of p16 regulation in GR-induced cellular lifespan extension. The decreased
expression of p16 was partly due to GR-induced chromatin remodeling through effects on histone acetylation and
methylation of the p16 promoter. GR resulted in an increased expression of SIRT1, a NAD-dependent histone deacetylase,
which has positive correlation with CR-induced longevity. The elevated SIRT1 was accompanied by enhanced activation of
the Akt/p70S6K1 signaling pathway in response to GR. Furthermore, knockdown of SIRT1 abolished GR-induced p16
repression as well as Akt/p70S6K1 activation implying that SIRT1 may affect p16 repression through direct deacetylation
effects and indirect regulation of Akt/p70S6K1 signaling. Collectively, these results provide new insights into interactions
between epigenetic and genetic mechanisms on CR-induced longevity that may contribute to anti-aging approaches and
also provide a general molecular model for studying CR in vitro in mammalian systems.
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Introduction
A growing body of evidence indicates that restricted caloric
intake is associated with lifespan extension and longevity in various
organisms including yeast, worms, flies and even mammals [1–5].
At the physiological and pathological levels, caloric restriction
(CR) can prevent the onset of many age-related degenerative
diseases such as cancer, cardiovascular disease and diabetes in
experimental animal models and human populations [6]. Hence,
CR is by far the most effective environmental manipulation to
extend maximum lifespan. Potential molecular mechanisms by
which CR induce longevity may involve oxidative or metabolic
pathways and more likely regulation changes of various age-
related genes [7–9]. However, the precise mechanisms of CR-
induced lifespan extension and longevity are not very well
understood. Therefore, finding the molecular mechanisms where-
by CR regulates lifespan has attractive potential in aging studies.
Epigenetic events are among the most striking mechanisms
responsible for nutrition-related longevity, which is believed to
dynamically regulate gene expression by primarily impacting two
epigenetic codes, DNA methylation and histone modification
[10–12]. As evidence of this, the yeast protein silent information
regulator 2 (Sir2), a nicotinamide adenine dinucleotide (NAD
+)-
dependent histone deacetylase (HDAC), is a key determinant in
CR-induced lifespan prolongation in yeast [5,13]. In mammali-
ans, SIRT1 is one of seven mammalian orthologs of Sir2, which
has been extensively studied for its roles in chromatin remodeling
and lifespan elongation. SIRT1 acts as a nutrient sensor involved
in the regulation of various gene expressions as well as
modulation of important signal transductions either directly or
indirectly through its unique epigenetic effects, which ultimately
influence the regulation of longevity [14]. Our previous studies
indicated that glucose restriction-induced DNA methylation
alteration in the p16 promoter contributes to cellular lifespan
extension [15]. In this regard, epigenetic mechanisms are major
molecular events which play a crucial role in CR-induced
longevity. Therefore, we speculated that an aging-associated gene
such as p16 may have a central position in epigenetic control of
PLoS ONE | www.plosone.org 1 February 2011 | Volume 6 | Issue 2 | e17421inhibition of cellular senescence and lifespan elongation in
response to CR.
The p16
INK4a gene, a cyclin-dependent kinase inhibitor, is
believed to play an important role in tumor growth suppression
and cell senescence [16,17]. The accumulation of p16 contributes
to senescence by negatively regulating the cell cycle in vitro and in
vivo [18,19]. In addition, p16 is also an epigenetic-regulated gene,
since its expression is frequently modulated by epigenetic processes
[20,21]. Further, our previous studies suggested that the
accumulation of p16
INK4a was attenuated by glucose restriction in
normal human lung fibroblasts in part by epigenetic control but
not repressed in precancerous fibroblasts of the same origin [15].
We therefore sought to investigate the molecular mechanisms of
epigenetic modulation of p16 expression, which will facilitate
approaches to anti-aging and anti-carcinogenesis studies.
Although the effect of CR in animal models is obvious, some
studies have revealed that the effects of CR-inducing longevity in
experimental animal models have varied, which may be due to
genetic variation between different species as well as different
living conditions for experimental animals [22,23]. Therefore,
these uncontrolled factors in CR animal models may reduce its
utility in mechanisms studies. However, a novel in vitro cellular
system for CR has more advantages such as flexible-control,
accuracy and identical genomic background as compared to the in
vivo systems. This system allows more precise analysis of molecular
mechanisms of CR specifically at the cellular level in addition to
the effects of CR on cellular lifespan. Previously we established an
in vitro system to mimic CR-controlled longevity by reduction of
glucose, the main caloric resource, in cell culture medium [15].
Hence we have extended our studies to elucidate fundamental
epigenetic mechanisms in regulating cellular lifespan in three
human normal fibroblasts in response to glucose restriction (GR).
We found that GR can extend cellular lifespan through inhibition
of the accumulation of p16. Perhaps most importantly, this is due
at least in part to epigenetic modulation of p16 expression through
SIRT1-dependent and -independent histone remodeling. Our
results also showed that SIRT1 can regulate Akt/p70S6K1
signaling that contributes to p16 suppression leading to longevity
in GR. This implies a novel crosstalking mechanism involving
epigenetic and genetic control of p16 regulation and also suggests
that SIRT1 has a key position in connecting of these two
mechanisms. Our findings not only reveal CR-involved epigenetic
mechanisms in cellular lifespan control, but also provide new
insights into nutrition-related anti-aging and anti-cancer ap-
proaches.
Results
GR delayed cellular senescence processes leading to
cellular lifespan extension in normal human fibroblasts
Our previous studies indicated that GR can increase the lifespan
of normal WI-38 fibroblasts. It is very important to verify that this
phenomenon occurs not only in a single cell type, but also in
multiple cell models. We therefore extended this study by
including two fetal lung fibroblasts such as MRC-5 and IMR-90
as well as WI-38 that we employed in our previous studies [15] to
allow multiple cell comparisons and further mechanistic analysis.
To restrain energy intake, we treated the fibroblasts with glucose
restriction (GR) medium, whereas the same batches of fibroblasts
treated with normal glucose (NG) level of medium served as
control. We monitored the cellular proliferation and population
doublings (PDs) during the entire cellular lifespan in three
fibroblast cell lines receiving either NG or GR medium.
Experiments were terminated when cells stopped proliferating
and underwent replicative senescence. As indicated in Fig. 1, the
lifespan of all three human fibroblasts cell lines grown in GR
medium was extended by an additional 2–4 weeks accompanied
by an additional 5–10 PDs, which constituted a 23–67%
prolongation of lifespan depending on different types of cells in
GR medium (Table 1). Notably, this extension did not proceed
prominently at the beginning of GR treatment, but rather, was
more noticeable during the late treatment of GR. For instance, in
WI-38 cells, a slightly reduced population doubling was observed
at the beginning of four week-treatment of GR. After that, glucose-
restricted WI-38 cells surpassed the maximal lifespan and
underwent a total expansion of lifespan by more than four weeks
with an additional 5.260.3 PDs (Fig. 1, left panel and Table 1)
compared with WI-38 cells in NG medium. These results indicate
that cells may need an adaptive process to undergo longevity
under the situations of GR or caloric restriction (CR) [6,7].
Consistent with our previous studies, this study further established
that CR can induce longevity not only in experimental animal
models, but more importantly, in a culture cellular system, which
may provide an excellent in vitro model for CR studies. It is also
notable that although GR extended the lifespan of all of the cell
lines we examined, this varies somewhat for different cells.
Figure 1. Glucose restriction extends lifespan of human fibroblasts. Cumulative population doubling curves of WI-38 (left), MRC-5 (middle)
and IMR-90 (right) in either normal glucose (NG) level or glucose restriction (GR) growth medium. Viable cells were counted weekly by trypan blue
staining using a hemacytometer. Population doublings were calculated by the formula log [(number of cells harvested)/(number of cells seeded)]/
log2. Each graph depicts the averaged results from three longevity assessments.
doi:10.1371/journal.pone.0017421.g001
Regulation of p16
INK4a by Glucose Restriction
PLoS ONE | www.plosone.org 2 February 2011 | Volume 6 | Issue 2 | e17421To determine the effect of GR on cellular senescence, we
quantified the proportion of senescent cells at their early and late
passages under the condition of either NG or GR medium by
using the senescence-associated b-galactosidase (SA-b-gal) activity
assay. We found a low proportion of senescent cells in all three
types of fibroblasts at the early stage of cell proliferation both in
NG and GR medium-treated cells (Fig. 2). Further, no prominent
differences in SA-b-gal activity were observed between fibroblast
cells with the treatment of NG and GR medium at early passage.
However, successive subculture resulted in significantly increased
senescent cells accumulation in NG medium versus GR medium at
late passage. This replicative senescence delay induced by GR
occurred at late passage rather than at early passage further
indicating a potential cellular metabolic adaptive process as
discussed above. Taken together, our results suggest that GR
significantly extends the lifespan of multiple cell lines through
suppressing cellular aging processes leading to a prolongation of
lifespan in vitro.
GR influenced cellular senescence through inhibition of
p16 expression
p16
INK4a (p16) is well known as a negative regulator of the
cellular cycle through inhibiting activation of cyclin D/CDK4/
CDK6 and subsequently releasing the inhibitory retinoblastoma
gene (Rb) [24]. More importantly, significant accumulation of p16
expression has been widely observed in a variety of aging tissues
both in animal models and humans indicating p16 plays an
important role in aging and can also serve as a potent aging
biomarker. Considering the important roles of p16 in aging, we
sought to define the patterns of p16 expression in normal human
cells during GR treatment.
As shown in Fig. 3A, we found that p16 mRNA gradually
accumulated under the NG condition, whereas GR decreased p16
transcription as cellular passages progressed in all of the three cell
lines we tested. In NG cells, p16 mRNA accumulated and reached
peak levels at the late passage indicating cellular senescence
processes were initiated. In contrast to NG treatment, GR resulted
in p16 expression suppression consistently during all cellular
passages. However, glucose-restricted IMR-90 cells, which result-
ed in the longest lifespan extension (66.7%), did not show a
maximal reduction of p16 expression compared with that in WI-38
and MRC-5 cells indicating that although p16 may serve a major
role in lifespan regulation, other factors could also be involved. To
elucidate p16 protein expression in response to NG and GR
medium, cellular proteins in WI-38 cells were extracted at every
other two week intervals and subjected to western blot assay. As
indicated in Fig. 3B, p16 protein gradually accumulated from the
early five weeks of proliferation in NG growth medium, whereas
the p16 protein signal was only detected at the later 12 weeks of
treatment with GR medium when cellular replicative senescence
may occur. Consistent with p16 mRNA expression in Fig. 3A,
these results suggest that GR-impaired p16 accumulation may
contribute to cellular lifespan extension.
Since p16 exerts its cellular growth inhibitory effects primarily
by negatively regulating Rb phosphorylation, we also examined
the p16/Rb signaling pathway response to GR. Our results
revealed a gradually increased p16 expression was accompanied
by reduced expression of phosphorylated Rb (Ser-795) in NG
medium during the cellular passaging (Fig. 3C). However, in GR
medium, p16 protein signals were barely detected and expression
of phosphorylated Rb was increased accordingly (Fig. 3C).
Therefore expression alterations of p16/Rb signaling were
consistent with the model that they are a consequence of changes
of cellular PDs and senescence in GR medium suggesting that GR
may contribute to increased cellular lifespan via inhibiting the
p16/Rb signaling pathway. Collectively, these data suggest that
GR or CR delays p16 accumulation and impairs the subsequent
p16/Rb signaling, which, in turn, inhibits cellular replicative
senescence contributing to cellular lifespan extension in normal
human cells.
Over-expressed p16 resulted in early cellular senescence
in glucose-restricted WI-38 cells
To determine the roles of p16 expression in CR-induced cellular
lifespan extension, reversed p16 expression was obtained by
transiently transfecting p16 into NG or GR-treated WI-38 cells at
intermediated passage. p16 protein was detected to verify
transfection efficiency and SA-b-activity was performed to
investigate cellular senescence as well (Fig. 4A). As shown in
Fig. 4B and 4C, p16 over-expression in GR but not in NG cells
caused a significant increase in senescent cells compared with the
cells transfected with mock vector in WI-38 cells, which implied
that p16 amount is more critical in senescence regulation under
GR rather than NG. These results also suggest that age-impairing
properties conferred by p16 reduction are abrogated when p16
expression is reversed, which further indicates the importance of
p16 expression in aging regulation during GR.
GR resulted in chromatin remodeling of the p16
promoter
Our previous studies have shown different chromatin remod-
eling patterns of the p16 gene regulatory region may contribute to
different cellular fates in normal and cancer cells in response to
GR [15]. We therefore extended our study to investigate the
epigenetic mechanisms involving GR-induced dynamic chromatin
remodeling in the p16 promoter in three normal human cell lines.
We initiated our experiments to determine chromatin patterns in
histone acetylation and methylation due to their important roles in
gene regulation. The transcriptional chromatin markers we used
included both transcriptionally active (acetyl-H3 and dimethyl-
H3K4) and inactive (trimethyl-H3K9) markers.
Table 1. Extension of population doublings and cellular lifespan in response to glucose restriction.
Cumulative population doublings
# Lifespan
Cell lines Glucose Glucose restriction Extension Percentage of extension (%)
WI-38 9.961.2 15.160.9 5.260.3 42.8
MRC-5 38.462.0 44.962.4 6.560.4 23.1
IMR-90 15.561.5 26.162.5 10.661.0 66.7
#The cumulative population doublings were calculated after the first confluent cells designed as PD 0.
doi:10.1371/journal.pone.0017421.t001
Regulation of p16
INK4a by Glucose Restriction
PLoS ONE | www.plosone.org 3 February 2011 | Volume 6 | Issue 2 | e17421We monitored the trend changes of these chromatin markers
during cell passage progression to detect the effects of chromatin
remodeling on p16 expression under NG or GR in three tested cell
lines. As shown in Fig. 5A (acetyl-H3) and 5B (dimethyl-H3K4),
the bindings of these active chromatin markers in the p16
promoter were significantly decreased by GR compared with
NG at most of the cellular passages in all three examined cell lines.
By contrast, GR significantly increased the binding of trimethyl-
H3K9, the inactive chromatin marker, to the p16 promoter
(Fig. 5C). We also found that GR-induced enrichment changes of
these chromatin markers were more significant in the intermediate
and late passages than in the early passage suggesting epigenetic
mechanisms may involve a metabolic adaptive response via p16
repression under GR as we discussed previously. It is very feasible
that the histone remodeling in the p16 promoter contributes to p16
transcription repression by increasing the compaction of histone
structures in local DNA replicative loci. More importantly, these
chromatin structural changes in the p16 promoter were consistent
with p16 expression patterns which suggested a strong cause-and-
effect relationship between epigenetic mechanisms and p16
regulation. Taken together, these results suggest that chromatin
modification may play a crucial role in CR-induced in vitro
longevity, at least partly due to epigenetic p16 repression and that
this occurs in all of the cell lines we examined.
Figure 2. GR delayed cellular senescent rate. Cellular senescence was determined by Senescence b-Galactosidase (SA-b-Gal) assay. Human
fibroblasts, WI-38 (upper), MRC-5 (middle) and IMR-90 (lower) treated with NG and GR growth medium were subjected to SA-b-Gal staining and
photographed in a proliferating state (early passage) and senescence (late passage). The definitions of early and late passages were mentioned in the
section of Experimental procedures. Magnification,6100. The rate of SA-b-Gal-positive cells (blue staining) was counted by the number of SA-b-Gal-
positive cells divided by the total number of cells in 5 randomly chosen fields. The graphs (right) shown are representative of the results obtained
from three independent experiments. Bars, SD; *, P,0.05, significantly different from NG control.
doi:10.1371/journal.pone.0017421.g002
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human fibroblasts
Numerous studies have demonstrated the pivotal role of
SIRT1 in lifespan prolongation in various species via regulating
epigenetic and genetic events. However, although extensive
studies have investigated the function of SIRT1 in longevity
and metabolic control in animal models, the precise effects of
SIRT1 on in vitro lifespan extension are not yet known. To
determine the roles of SIRT1 in cellular longevity under the
circumstance of CR in vitro, we analyzed the changes of SIRT1
expression and its histone deacetylase enzymatic activity in
human lung fibroblasts in the presence or absence of GR. We
Figure 3. GR resulted in p16 repression. A. Graphic presentation of relative mRNA levels of p16 in WI-38 (left), MRC-5 (middle) and IMR-90 (right)
cells during early, intermediate and late proliferation of cell growth. Human fibroblasts were cultured in NG or GR medium as indicated previously.
Data are in triplicate from three independent experiments and were normalized to GAPDH. p16 mRNA level at PD 0 was calibrated to 1. Columns,
mean; Bars, SD; *, P,0.05, significantly different from p16 mRNA level at PD 0. B. The protein levels of p16 were determined by western-blot analysis.
WI-38 cell proteins were extracted once every two weeks until cells ceased growth and underwent replicative senescence. C. The protein expression
of p16 and phosphorylated Rb (p-Rb) were detected in human fibroblasts, WI-38 (upper), MRC-5 (middle) and IMR-90 (lower), during early,
intermediate and late proliferation of cell growth. The definitions of early, intermediate and late passages were described above. Cells were treated
with/without GR medium as described above. Membranes were reprobed with anti-GAPDH antibody to ensure for equal loading. Representative
photographs are derived from three independent experiments.
doi:10.1371/journal.pone.0017421.g003
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(Fig. 6A) and protein levels (Fig. 6B) expression, most notably
in late passage of cell growth and that this applied to all of the cell
lines we examined. Accordingly, SIRT1 histone deacetylase
activities were also found to be elevated significantly and were
accompanied by an increased binding of SIRT1 in the p16
promoter (Fig. 6C). Among three tested fibroblasts, GR-treated
IMR-90 cells with the longest lifespan extension have shown a
prominent elevated SIRT1 HDAC activity and binding prefer-
ence in the p16 promoter indicating that CR-controlled SIRT1
epigenetic regulation may occupy a central position in determi-
nation of maximal cellular lifespan. These results strongly suggest
that this increased SIRT1 may contribute to cellular lifespan
extension and aging impairment, which may regulate age-related
genes such as p16 due to its epigenetic and potentially genetic
effects.
GR resulted in activation of Akt/p70S6K1 signaling
A large number of publications have reported the importance
of Akt signaling on cellular proliferation, metabolism and survival
control under nutritional stress [25,26]. To investigate the precise
molecular mechanisms on CR-induced longevity, we examined
the Akt kinase pathway and its downstream target, mammalian
target of rapamycin (mTOR) in WI-38 cells. As shown in Fig. 7A,
phosphorylated Akt and Akt protein kinase showed an increased
expression trend during increased PDs in response to GR. Since
evidence has shown activation of the Akt pathway induces cell
cycle progression due to p16 repression, our result indicated that
GR-induced activated Akt signaling may play an important role
in promoting cellular proliferation under the stress of nutrition
deficiency via regulation of p16 expression. The downstream
pathway of Akt, mTOR signaling, also plays an important role in
longevity in different organisms such as yeast, worms and flies
[27]. Mutant mTOR or rapamycin, the inhibitor of mTOR, have
been showed to extend the lifespan in yeast and mice [28].
p70S6K1 is a downstream target of Akt and its activation
depends on the phosphorylation of several residues of the
p70S6K1 protein, such as Ser-389 and Ser-421/Thr-424 [29].
Activation of p70S6K1 is also associated with a decrease in the
expression of p16 [30,31]. Consistently, our results showed that
GR caused a decreased expression of mTOR and its dependent
protein kinases, phosphorylated p70S6K1 (Thr-389, Thr-421/
Ser-424), whereas it did not affect the expression of p70S6K1
total protein, compared with the protein expression in NG. This
suggests that inactivation of mTOR signaling may also contribute
to CR-induced longevity in vitro. However, a gradient accumu-
lation of mTOR/p70S6K1 protein in GR may result in p16
silencing due to the enhanced activation of p70S6K1 signaling. In
addition, decreased expression patterns in mTOR signaling were
found in senescence cells exposed to NG medium indicating the
reduction in mTOR/S6K1 signaling may be essential in cellular
aging processes (Fig. 7A). Collectively, our results illustrated the
important role of Akt/p70S6K1 on cell cycle and senescence
regulation and that this effect may be implemented through the
inhibition of p16, which contributes to lifespan elongation under
nutrition stress in vitro.
SIRT1 inhibition abolished Akt/p70S6K1-induced p16
repression
To further investigate the role of SIRT1 in regulation of p16
repression, RNAi approaches were performed to repress SIRT1
expression in glucose/glucose restricted-WI-38 cells. As indicated
in Fig. 7B, we found that SIRT1 inhibition resulted in reactivation
of the p16/Rb pathway regardless of nutrition conditions.
However, this effect was more efficient and prominent under
nutritional stress suggesting that activation of SIRT1 could induce
longevity through, at least in part, negative regulation of the p16/
Rb pathway. We also examined whether SIRT1 suppression can
Figure 4. Reversed expression of p16 accelerated cellular senescence in glucose-restricted WI-38 cells. NG and GR treated WI-38 cells
were transiently transfected with empty vector or with cDNA encoding p16.A .p16 expression was verified by western-blot analysis. B. SA-b-Gal assay
was used for determining cellular senescence in the post-transfected WI-38 cells. C. The representative graphs showed the rate of SA-b-Gal-positive
cells from three independent experiments. Columns, mean; Bars, SD; *, P,0.05, significantly different from vehicle control.
doi:10.1371/journal.pone.0017421.g004
Regulation of p16
INK4a by Glucose Restriction
PLoS ONE | www.plosone.org 6 February 2011 | Volume 6 | Issue 2 | e17421affect the Akt/p70S6K1 signaling pathway, thereby influencing
the p16/RB pathway. We observed that SIRT1 inhibition
abrogated the activation of Akt kinase, mTOR, phosphorylated
p70S6K1 (Thr-389, Thr-421/Ser-424) and p70S6K1 (Fig. 7B),
suggesting that SIRT1 regulated the p16/RB pathway through the
Akt/p70S6K1 signaling pathway. In summary, our results
revealed a working network involving both epigenetic and genetic
control on p16 regulation under nutrition stress. This model
indicated SIRT1 may pose a central role in p16 repression through
direct deacetylation and directly/indirectly modulating Akt/
p70S6K1 signaling under the circumstance of nutrition stress
(Fig. 8). As a consequence, p16 repression promotes cellular
proliferation and postpones senescence which in turn contributes
to lifespan extension and longevity in CR.
Figure 5. Histone modification changes of the p16 promoters in response to GR. GR-treated and -untreated human fibroblasts including
WI-38 (left), MRC-5 (middle) and IMR-90 (right) were analyzed by ChIP assays. Enrichment changes of three chromatin markers including two
activators, acetyl-H3 (A) and dimethyl-H3K4 (B) and one repressor, trimethyl-H3K9 (C), in the p16 promoter were tested during early, intermediate and
late proliferation of cell growth. The relative enrichment of individual chromatin markers was obtained from ChIP PCR and calculated as the ratio
between the net intensity of each bound sample divided by the input. Inputs came from the total DNA and served as the same ChIP PCR conditions.
Representative photograph from an experiment was repeated three times. Columns, mean; Bars, SD; *, P,0.05, significantly different from the
corresponding NG control.
doi:10.1371/journal.pone.0017421.g005
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Over the past few decades, numerous studies have established
that calorie restriction (CR) is the only environmental intervention
known to extend maximum lifespan in various species ranging
from yeast, worms, flies, mice and even nonhuman primates [1–5].
The mechanisms involving the prominent impact of CR on
lifespan may be attributed to reduction of the onset of many age-
related degenerative diseases, in particular, cancer genesis [6]. At
the molecular levels, CR can frequently decrease the expression of
age-related genes, thus leading to aging delay and lifespan
elongation [9]. Hence CR can extend lifespan mainly through a
Figure 6. GR-induced activation of SIRT1 expression, HDAC enzymatic activity and binding ability in human fibroblasts. A and B.
Expression of SIRT1 in WI-38 (left), MRC-5 (middle) and IMR-90 (right) cells by the treatment of NG and GR growth medium during early, intermediate
and late proliferation of cell growth. A, mRNA levels of SIRT1 expression. Representative graphic came from three independent experiments and were
normalized to GAPDH and calibrated to SIRT1 mRNA level at PD 0. Columns, mean; Bars, SD; *, P,0.05, significantly different from SIRT1 mRNA level
at PD 0. B. The protein levels of SIRT1 were determined by western-blot analysis. Representative photographs were obtained from three independent
experiments. C. Alterations of SIRT1-HDAC enzymatic activity (columns) and binding ability in the p16 promoter (lines) in response to GR. Nuclear
proteins of human fibroblasts of WI-38 (left), MRC-5 (middle) and IMR-90 (right) cells were extracted at the intermediate progress of cell proliferation.
SIRT1 HDAC activity assays were performed according to the manufacturer’s protocols. The relative binding ability of SIRT1 to the p16 promoter was
evaluated by ChIP assay and calibrated to NG values. The values of HDAC enzymatic activities and binding enrichments of SIRT1 are the means of
three independent experiments. Columns or lines, mean; Bars, SD; *, P,0.05, **, P,0.01, significantly different from NG control.
doi:10.1371/journal.pone.0017421.g006
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alteration and regulation of age-related key genes such as p16
during CR will not only facilitate exploration of the precise
mechanisms involving CR-induced longevity, but also provide
inspiration for human aging studies.
In our current studies, we focused on studying the epigenetic and
genetic regulation of an important age-related gene, p16, in normal
human fetal lung fibroblasts during GR. Our results demonstrated
that reduced glucose in the culture medium extended cellular
lifespan which was accompanied by a reduction in cellular
replicative senescence. This increased lifespan was due, at least in
part, to p16 repression by epigenetic chromatin remodeling and
activation of SIRT1-mediated epigenetic and genetic regulation.
Thus, this study suggests a novel regulation network targeted to
epigenetic and genetic control of p16 expression under the situation
of CR and may facilitate an approach to potentially manipulate
aging and age-related disease prevention.
Although extensive studies have confirmed that CR can induce
longevity in various animal models, evidence is extremely deficient
in human studies and in vitro studies have not yet been established.
We therefore initiated our CR studies in normal human fibroblasts
such as WI-38, MRC-5 and IMR-90 cells, by limiting the
concentration of their main caloric resource, glucose, in cell
culture medium to obtain CR. We found glucose restriction (GR)
significantly extended cellular lifespan in vitro, which is consistent
with previous in vivo CR studies [1–4]. This extended lifespan
correlated with decreased cellular senescence rate suggesting that
CR-induced longevity is primarily due to cellular age-delaying
effects. Therefore, testing the regulation of important aging control
genes during CR may help to understand the mechanisms of CR
on aging processes.
Our previous finding showed a differential p16 expression
pattern in normal WI-38 and SV-40 transfected immortalized WI-
38 cells may result in different cell fates by which normal cells
maintain viability, and the immortalized cells underwent apoptosis
in response to glucose deficiency in culture medium [15]. These
studies raised the possibility that p16 regulation is essential in CR-
induced nutrient stress adaption and a consequence of longevity.
In this study, we therefore examined p16 expression and found a
gradient p16 accumulation with advancing senescence processes in
Figure 7. SIRT1 repressed p16 expression through activation of Akt/p70S6K1. A. Protein expression of Akt/p70S6K1 signaling during early,
intermediate and late proliferation of cell growth. Protein from GR-treated or untreated WI-38 cells was transferred to the nitrocellulose membrane
and probed with the specific antibodies against Akt, phosphorylated-Akt (Thr-308), mTOR, p70S6K1 and phosphorylated-p70S6K1 (Thr-389, Thr-421/
Ser-424). B. Repressed SIRT1 abrogated p16 inhibition through regulation of Akt/p70S6K1 signaling. GR-treated or untreated WI-38 cells were
transfected with SIRT1 siRNA to inhibit SIRT1 expression and extracted protein after three days of transfection. Protein expression alteration of SIRT1,
p16, p-Rb and Akt/p70S6K1 signaling were detected. Membranes were reprobed with anti-GAPDH antibody to ensure for equal loading.
Representative graphic came from three independent experiments.
doi:10.1371/journal.pone.0017421.g007
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occurred during CR. Coordinated expression patterns of pRb with
p16 changes further indicated that the effect of CR on aging delay
may be due to the suppression of the p16/Rb pathway. However,
glucose-restricted IMR-90 cells which resulted in the longest
lifespan extension (66.7%) did not show a prominent change of
p16 expression among three tested cell lines indicating that p16
signaling-induced aging postponement may not be the only
causative factor although it otherwise correlates with lifespan
extension in CR. More importantly, overexpression of p16
accelerated cellular senescence in GR fibroblasts rather than in
NG cells, which further verified the important role of p16 in CR. It
was reported that p16 acts as a robust biomarker of aging since
increased expression of p16 was observed in almost all the organs
in rodents with advancing age [17]. Consistent with those in vivo
studies, our results suggest that age-associated p16 accumulation
can be attenuated by CR resulting in aging delay and lifespan
elongation in cellular aging models.
Although the mechanism connecting this interesting phenom-
enon is not yet clear, growing evidence showing epigenetic
controls on gene regulation and stress modulation led us to
speculate that epigenetic mechanisms such as DNA methylation
and chromatin modification may play important roles in p16
regulation in CR [10–12]. It has been extensively reported that
p16 expression is frequently regulated by epigenetic events [20,21].
Our previous studies also indicated that GR-induced DNA
hypermethylation of the p16 promoter impaired E2F-1 binding,
thus influencing p16 expression [15]. Chromatin remodeling
including histone acetylation, methylation and phosphorylation,
also contributes to p16 regulation [33]. Here we observed the
alteration of chromatin structure was coordinated with p16
expression patterns in response to GR in all tested cell lines.
These results suggest that chromatin modifications influence p16
expression and also raise a possibility that chromatin-regulation
genes such as SIRT1 may also be involved in this process.
SIRT1 belongs to the type III histone deacetylase (HDAC)
family and its enzymatic activity is primarily dependent on NAD
+
(nicotinamide adenine dinucleotide) [34]. SIRT1 is believed to
play a crucial role in gene regulation by its epigenetic (chromatin
remodeling) and genetic (interacting with a number of transcrip-
tion factors) effects to obtain stress resistance and longevity under
the circumstance of nutrition deficiency [35–39]. In this context,
SIRT1 is speculated to suppress p16 expression in a similar
manner. This hypothesis was validated by our results showing that
GR resulted in a significant increase of SIRT1 expression, its
histone deacetylase enzymatic activity and its binding ability to the
p16 promoter as well. In addition, a more significant change in
SIRT1 HDAC activity and binding ability to the p16 promoter
was found in GR IMR-90 cells which have the longest lifespan
extension suggesting that SIRT1 epigenetic regulation may play a
key role in determination of maximal lifespan under CR. This
activated SIRT1 may block senescence by direct deacetylation of
p16, or indirectly impacting certain signal transductions leading to
longevity.
We also analyzed the Akt protein kinase signaling pathway not
only because the Akt pathway plays major roles in cellular growth,
metabolism and aging regulation, but also because Akt activation
is associated with p16 inhibition [25]. In addition, Akt downstream
mTOR-p70S6K1 signaling is very important in CR because
mTOR acts as a ‘‘metabolic checkpoint’’ in that its activation is
tightly dependent on the presence of nutrition [40]. Moreover,
activation of the mTOR downstream target, p70S6K1, is reported
to be relevant to p16 repression implying a potential role of
p70S6K1 in aging and longevity regulation [31]. Consistent with
these reports, our results demonstrated that CR caused activation
of Akt/p70S6K1 signaling, indicating these altered signaling
pathways conferred a beneficial effect on cell survival and age-
delaying through regulation of p16 expression in response to
nutrition deficiency. It was proposed that SIRT1 functions as a
nutrient-sensitive growth suppressor gene through regulating
multiple signaling pathways including p70S6K1 signaling
Figure 8. Schematic model for epigenetic and genetic regula-
tion of p16 repression during CR. CR-induced SIRT1 activation in
human lung fibroblasts can suppress the p16/Rb pathway through its
direct deacetylation effects (epigenetic mechanisms) and indirectly
provoking Akt/p70S6K1 signaling (genetic mechanisms). CR can also
directly affect epigenetic remodeling in the p16 promoter which
contributes to p16 repression. As a result, p16 repression leads to aging
delay and cellular lifespan extension.
doi:10.1371/journal.pone.0017421.g008
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the p16/Rb pathway accompanied by an attenuation of Akt/
p70S6K1 signaling. This suggests that SIRT1 can repress p16
expression through, at least in part, interacting with Akt/p70S6K1
signaling, leading to longevity in response to CR.
Based on our current study, we propose a potential model
where negative regulation of p16 is mainly mediated by SIRT1
through epigenetic and genetic mechanisms during CR (Fig. 8).
SIRT1, acting as a ‘‘nutrition sensor’’, sensitively responds to
environmental nutrition alteration through regulation of various
genes that might involve growth control, stress and aging as well.
p16 is known as an important target gene of SIRT1 in a series of
physiological and pathological processes including aging and
tumorigenesis [16,17]. According to our theory, CR-induced
SIRT1 represses the p16/Rb pathway resulting in cell cycle
progression, leading to replicative senescence postponement and
longevity. p16 repression was achieved by direct epigenetic
silencing though universal chromatin remodeling in the p16
promoter as well as the increased deacetylation activity of SIRT1,
and indirect regulation by interaction with the Akt/p70S6K1
signaling pathway.
Collectively, our findings provide potential mechanisms by
which CR leads to aging delay and lifespan extension via
regulation of a robust aging biomarker, p16, in normal human
fibroblasts. More importantly, our results demonstrate a crosstalk
model involving SIRT1-mediated epigenetic and genetic regula-
tion on p16 repression in CR. The important role of CR on aging
and age-related diseases such as cancer, has opened an attractive
approach to potentially manipulate aging to achieve the ultimate
goal of impacting longevity in humans. Our study helps to
elucidate the basic mechanisms underlying key gene regulation
during nutrition deficiency, which will benefit development of
effective therapeutic strategies for aging and age-associated
diseases.
Materials and Methods
Cell culture and growth kinetics assessment
Normal diploid WI-38, MRC-5 and IMR-90 human fetal lung
fibroblasts were obtained from American Type Culture Collection
(Manassas, VA, USA). The cells were within the range of 15–20
population doublings (PDs) upon initiation of the experiment.
Cells were maintained in DMEM (Invitrogen, Carlsbad, CA,
USA) medium supplemented with 4.5 g/L glucose. To restrain
glucose, cells were cultured in glucose- and pyruvate-free DMEM
medium (Invitrogen). All culture media were supplemented with
10% fetal bovine serum (Atlanta Biologicals, Lawrenceville, GA,
USA) and 1% penicillin/streptomycin (Mediatech, Herndon, VA,
USA) in the presence of 5% CO2 at 37uC. The actual glucose
concentration in the glucose restriction medium was 15 mg/L,
which was assessed by the Glucose Assay kit (Biovision, Mountain
view, CA, USA) following the manufacturer’s protocols.
To quantify replication, cells were passaged weekly at a seeding
density of 10
5 cells per plate and counted using a Neubauer
haemocytometer until cells reached 90–95% confluence. Cellular
PDs were calculated based on the following formula: log [(number
of cells harvested)/(number of cells seeded)]/log2 [41]. The first
confluent cells while the experiments initiated were designated as
PD 0. The duration of cellular lifespan was equally divided in
three stages including early, intermediate and late passages.
Cellular replicative senescence at the end of late passage in cellular
lifespan was determined by morphological changes and senes-
cence-associated b-Galactosidase activity assay as described below.
The PD ranges of early, intermediate and late passages in WI-38,
MRC-5 and IMR-90 cells with either NG or GR treatment are
shown in Table 2.
Senescence-associated b-Galactosidase activity assay
The normal human fetal lung fibroblasts (WI-38, MRC-5 and
IMR-90) were treated with normal glucose and glucose restriction
medium as described preciously [15]. Cellular senescence was
assessed by using the Senescence b-Galactosidase staining kit (Cell
Signaling, Beverly, MA, USA). In particular, cells were washed
twice in phosphate-buffered saline (PBS) and then fixed in 0.5%
glutaraldehyde for 10 min at room temperature. After a second
wash with PBS, the cells were incubated at 37uC with fresh
senescence associated b-Gal (SA-b-Gal) stain solution containing
1 mg/ml of 5-bromo-4-chloro-3-indolyl-beta-D-galactoside (X-
Gal) overnight according to the manufacturer’s protocols. The
senescence-associated b-galactosidase (SA-b-Gal)-positive cells
were counted by using a Nikon Coolpix990 digital camera (Nikon,
Tokyo, Japan) at 40-fold magnification. Counts were performed at
five random locations in the same well and every field was counted
three times for determination of the mean percentage of positively
stained cells.
Quantitative real-time PCR
All glucose restriction treated- and untreated-human lung
fibroblasts were harvested and total RNA was extracted using
the RNeasy kit (Qiagen, Valencia, CA, USA) once a week during
the cellular lifespan. Total RNA (5 mg) was reverse transcribed to
cDNA using the Superscript II kit (Invitrogen, Carlsbad, CA,
USA) with oligo-dT primer. In the real-time PCR step, PCR
reactions were performed in triplicate with 1 mg cDNA per
Table 2. Representation of population doublings in early, intermediate and late passages of cell growth in either NR or GR
medium.
Cell lines WI-38 MRC-5 IMR-90
Population doublings
@ Population doublings
@ Population doublings
@
Glucose status E
# I
* L
& E
# I
* L
& E
# I
* L
&
NG 0–3 4–6 7–10 0–13 14–27 28–40 0–5 6–11 12–16
GR 0–4 5–10 11–15 0–15 16–30 31–45 0–9 10–19 20–27
@ The population doublings were calculated after the first confluent cells designed as PD 0;
# early passage;
* intermediated passage;
& late passage.
doi:10.1371/journal.pone.0017421.t002
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(Hs01009006_ml) and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) (Hs99999905_ml) provided by Inventoried Gene Assay
Products (Applied Biosystems, Foster City, CA, USA) using the
Platinum Quantitative PCR Supermix-UDG (Invitrogen) in a
Roche LC480 thermocycler. Thermal cycling was initiated at
94uC for 4 min followed by 35 cycles of PCR (94uC, 15 s; 60uC,
30 s). GAPDH was used as an endogenous control, and normal
glucose control was used as a calibrator. The relative changes in
gene expression were calculated using the following formula: fold
change in gene expression, 2
-DDCt=2
-{DCt (Glucose restriction) - DCt
(Normal glucose control)}, where DCt=Ct (p16 or SIRT1) - Ct
(GAPDH) and Ct represents threshold cycle number.
Antibodies and immunoblotting
Antibodies against p16
INK4a (Santa Cruz Biotechnology, Santa
Cruz, CA), phosphorylated-Rb (Ser-795) (Cell Signaling, Danvers,
MA), SIRT1 (Abcam, Cambridge, MA), Akt123 (Cell Signaling),
p-Akt123 (Thr-308) (Cell Signaling), mTOR (Cell Signaling),
phosphorylated-p70S6K1 (Thr-389, Thr-421/Ser-424) (Cell Sig-
naling) and GAPDH (Santa Cruz Biotechnology) were used in this
study.
For western blot analysis, protein extracts were prepared by
RIPA lysis buffer (Upstate Biotechnology, Temecula, CA) from
normal fetal lung fibroblasts in normal or glucose restricted
medium according to the manufacturer’s protocol. Proteins
(50 mg) were electrophoresed on a 10% SDS-polyacrylamide gel
and transferred to nitrocellulose membranes. Membranes were
probed with the corresponding antibody, then the membrane was
stripped and reprobed with GAPDH as loading control. Molecular
weight markers were run on each gel to confirm the molecular size
of the immunoreactive proteins. Immunoreactive bands were
visualized using the enhanced chemiluminescence detection
system (Santa Cruz Biotechnology) following the protocol of the
manufacturer.
Transient transfection of human fetal lung fibroblast
WI-38 cells
pcDNA p16 (expression plasmid) and pcDNA 3.1 (empty vector)
plasmids were transiently transfected into NG or GR WI-38 cells
at intermediate passage using Lipofectamine 2000 (Invitrogen)
according to the manufacturer’s protocol. After 72 h post-
transfection, cellular protein was extracted and western-blot assays
were performed to verify the expression of exogenous p16 while
empty vector transfection served as a negative control. The same
batch of cells was subjected to SA-b-Gal staining as described
above.
Chromatin immunoprecipitation (ChIP) assays
Human fetal lung fibroblast cells were cultured in 100 mm
tissue culture dishes and harvested at the indicated time points.
ChIP assays were performed with the EZ Chromatin Immuno-
precipitation (EZ ChIP
TM) assay kit according to the manufac-
turer’s protocol (Upstate Biotechnology) as reported previously
[15]. The antibodies used in the ChIP assays were ChIP-validated
acetyl-histone H3 (Upstate Biotechnology), dimethyl-histone H3
(Lys4) (Upstate Biotechnology), trimethyl-histone H3 (Lys9)
(Upstate Biotechnology), SIRT1 (Abcam) respectively. In addition,
appropriate controls including positive control (RNA polymerase
antibody), negative control (mouse IgG) and internal control
(input) were established to optimize the ChIP conditions. ChIP-
purified DNA was amplified by standard PCR using primers
specific for the p16 promoter. The p16 ChIP primers were sense,
59- TAGGAAGGTTGTATCGCGGAGG -39, and anti-sense 59-
CAAGGAAGGAGGACTGGGCTC -39 rendering a 172 bp
PCR product. PCR amplification was performed using the
26PCR Master Mix (Promega) and the reaction was initiated at
94uC for 4 min followed by 30 cycles of PCR (94uC, 30 s; 56uC,
30 s; 72uC, 1 min), and extended at 72uC for 5 min. After
amplification, PCR products were separated on 1.5% agarose gels
and visualized by ethidium bromide fluorescence using Kodak 1D
3.6.1 image software (Eastman Kodak Company, Rochester, NY,
USA). Quantitative data were analyzed using the Sequence
Detection System software version 2.1 (PE Applied Biosystems,
Foster City, CA, USA).
Histone deacetylase activities of SIRT1
Cultured cells were harvested at the indicated period of
treatment, and nuclear extracts were prepared with the nuclear
extraction reagent (Pierce, Rockford, IL). The HDAC activity
assays (Active Motif, Carlsbad, CA, USA) were performed
according to the manufacturer’s protocols. NAD (Sigma, St.
Louis, MO, USA) was added into the assay buffer to activate
SIRT1 activity and nicotinamide served as an inhibitor. The
enzymatic activities of HDAC were detected by a microplate
reader at 450 nm.
RNA interference
Validated siRNA for SIRT1 (Santa Cruz Biotechnology) and
the appropriate control RNAi (Applied Biosystems) were trans-
fected into WI-38 cells using the Silencer siRNA Transfection II
Kit (Applied Biosystems) according to the protocols provided by
the manufacturer. To verify the result of SIRT1 gene knockout,
western-blot assay was performed using the antibody against
SIRT1.
Statistical analyses
Results from real-time PCR assays were derived from at least
three independent experiments. Kodak 1D 3.6.1 image software
was used for quantification of ChIP products. Statistical
significance between treatment and control groups was evaluated
with one-way ANOVA followed by the Dunnett post-test using the
Prism3 GraphPad software. Significance level was calculated using
an assigned confidence interval of 95%. P,0.05 was considered
statistically significant.
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